Abcellera Biologics Inc (ABCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 8,955 | 17,084 | 4,235 | 5,049 | 6,507 |
| Gross Profit | 8,955 | 17,084 | 4,235 | 5,049 | 6,507 |
| Operating Expenses | 85,233 | 66,669 | 66,895 | 77,804 | 100,170 |
| Operating Income | -76,278 | -49,585 | -62,660 | -72,755 | -93,663 |
| Other Income | 7,510 | 13,241 | 9,676 | 25,926 | 31,031 |
| Pre-tax Income | -68,768 | -36,344 | -52,984 | -46,829 | -62,632 |
| Income Tax | -11,649 | -1,617 | -7,363 | -12,619 | -11,525 |
| Net Income Continuous | -57,119 | -34,727 | -45,621 | -34,210 | -51,107 |
| Net Income | $-57,119 | $-34,727 | $-45,621 | $-34,210 | $-51,107 |
| EPS Basic Total Ops | -0.19 | -0.12 | -0.15 | -0.11 | -0.17 |
| EPS Basic Continuous Ops | -0.19 | -0.12 | -0.15 | -0.12 | -0.17 |
| EPS Diluted Total Ops | -0.19 | -0.12 | -0.15 | -0.11 | -0.17 |
| EPS Diluted Continuous Ops | -0.19 | -0.12 | -0.15 | -0.12 | -0.17 |
| EPS Diluted Before Non-Recurring Items | -0.19 | -0.12 | -0.15 | -0.11 | -0.17 |
| EBITDA(a) | $-69,042 | $-42,525 | $-56,055 | $-58,855 | $-55,368 |